Neuronal NF-kappa B ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination

Lee D-H, Kubera K, Rosenthal B, Kaltschmidt B, Kaltschmidt C, Gold R, Linker RA (2012)
Journal of Neuroimmunology 246(1-2): 38-42.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ;
Abstract
Neuro-axonal damage is a major hallmark of multiple sclerosis (MS). To date, not much is known on the underlying mechanisms of neuronal degeneration. In disease model myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis (MOG-EAE), there is a significant loss of alpha motorneurons in the cervical as well as thoracic and lumbar spinal cord. We further investigate the role of activated NF-kappa B for neuronal damage in a conditional ablation mouse model. A calcium calmodulin kinase II promoter-driven tetracycline transactivator is employed to regulate the expression of a human transdominant negative I kappa B-alpha mutant in the basal forebrain and selected neuronal subpopulations in the cerebellum and spinal cord including cerebellar Purkinje cells and spinal cord alpha motorneurons. In these mice with conditional neuronal NF-kappa B ablation, the clinical course of MOG-EAE, parameters of inflammation and axonal densities in the spinal cord white and grey matter as well as numbers of alpha motorneurons are not different to littermate controls. In conclusion, neuronal NF-kappa B ablation does not modulate neurodegeneration in autoimmune demyelination. (C) 2012 Elsevier B.V. All rights reserved.
Publishing Year
ISSN
PUB-ID

Cite this

Lee D-H, Kubera K, Rosenthal B, et al. Neuronal NF-kappa B ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination. Journal of Neuroimmunology. 2012;246(1-2):38-42.
Lee, D. - H., Kubera, K., Rosenthal, B., Kaltschmidt, B., Kaltschmidt, C., Gold, R., & Linker, R. A. (2012). Neuronal NF-kappa B ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination. Journal of Neuroimmunology, 246(1-2), 38-42.
Lee, D. - H., Kubera, K., Rosenthal, B., Kaltschmidt, B., Kaltschmidt, C., Gold, R., and Linker, R. A. (2012). Neuronal NF-kappa B ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination. Journal of Neuroimmunology 246, 38-42.
Lee, D.-H., et al., 2012. Neuronal NF-kappa B ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination. Journal of Neuroimmunology, 246(1-2), p 38-42.
D.-H. Lee, et al., “Neuronal NF-kappa B ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination”, Journal of Neuroimmunology, vol. 246, 2012, pp. 38-42.
Lee, D.-H., Kubera, K., Rosenthal, B., Kaltschmidt, B., Kaltschmidt, C., Gold, R., Linker, R.A.: Neuronal NF-kappa B ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination. Journal of Neuroimmunology. 246, 38-42 (2012).
Lee, De-Hyung, Kubera, Katharina, Rosenthal, Bastian, Kaltschmidt, Barbara, Kaltschmidt, Christian, Gold, Ralf, and Linker, Ralf A. “Neuronal NF-kappa B ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination”. Journal of Neuroimmunology 246.1-2 (2012): 38-42.
This data publication is cited in the following publications:
This publication cites the following data publications:

4 Citations in Europe PMC

Data provided by Europe PubMed Central.

Role of glial 14-3-3 gamma protein in autoimmune demyelination.
Lee DH, Steinacker P, Seubert S, Turnescu T, Melms A, Manzel A, Otto M, Linker RA., J Neuroinflammation 12(), 2015
PMID: 26438180
NF-κB signaling regulates myelination in the CNS.
Blank T, Prinz M., Front Mol Neurosci 7(), 2014
PMID: 24904273
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Mc Guire C, Prinz M, Beyaert R, van Loo G., Trends Mol Med 19(10), 2013
PMID: 24007818

21 References

Data provided by Europe PubMed Central.

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.
Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D., Nature 376(6536), 1995
PMID: 7603567
Axon pathology in neurological disease: a neglected therapeutic target.
Coleman MP, Perry VH., Trends Neurosci. 25(10), 2002
PMID: 12220882
A role for neuronal NF-κB in suppressing neuroinflammation and promoting neuroprotection in the CNS.
Emmanouil M, Taoufik E, Tseveleki V, Vamvakas SS, Probert L., Adv. Exp. Med. Biol. 691(), 2011
PMID: 21153363
Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection.
Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J, Kaltschmidt C, Israel A, Memet S., J. Neurosci. 23(28), 2003
PMID: 14561868
Brain synapses contain inducible forms of the transcription factor NF-kappa B.
Kaltschmidt C, Kaltschmidt B, Baeuerle PA., Mech. Dev. 43(2-3), 1993
PMID: 8297787
Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody.
Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H, Baeuerle PA., Biol. Chem. Hoppe-Seyler 376(1), 1995
PMID: 7612189
Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.
Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C., Proc. Natl. Acad. Sci. U.S.A. 96(16), 1999
PMID: 10430956
Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells.
Kaltschmidt B, Heinrich M, Kaltschmidt C., Neuromolecular Med. 2(3), 2002
PMID: 12622408
Signaling via NF-kappaB in the nervous system.
Kaltschmidt B, Widera D, Kaltschmidt C., Biochim. Biophys. Acta 1745(3), 2005
PMID: 15993497
NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling.
Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, Prullage M, Pfeiffer J, Lindecke A, Staiger V, Israel A, Kaltschmidt C, Memet S., Mol. Cell. Biol. 26(8), 2006
PMID: 16581769
CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.
Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R., Nat. Med. 8(6), 2002
PMID: 12042814
Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Luhder F, Gold R., Brain 133(Pt 8), 2010
PMID: 20826430
Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging
Mackenzie-Graham, NeuroImage 60(), 2011
Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions.
Mews I, Bergmann M, Bunkowski S, Gullotta F, Bruck W., Mult. Scler. 4(2), 1998
PMID: 9599334
NF-kappa B: a crucial transcription factor for glial and neuronal cell function.
O'Neill LA, Kaltschmidt C., Trends Neurosci. 20(6), 1997
PMID: 9185306
Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord.
Schirmer L, Albert M, Buss A, Schulz-Schaeffer WJ, Antel JP, Bruck W, Stadelmann C., Ann. Neurol. 66(5), 2009
PMID: 19938172
Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F., Trends Neurosci. 33(4), 2010
PMID: 20153532
Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice.
van Loo G, De Lorenzi R, Schmidt H, Huth M, Mildner A, Schmidt-Supprian M, Lassmann H, Prinz MR, Pasparakis M., Nat. Immunol. 7(9), 2006
PMID: 16892069
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J, Paul F, Aktas O, Muller-Wielsch K, Dorr J, Dorr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F., Ann. Neurol. 66(3), 2009
PMID: 19798635

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 22475633
PubMed | Europe PMC

Search this title in

Google Scholar